Bert Oosting Life Sciences - Netherlands

You are here Home  > Life Sciences >  Bert Oosting
Item image

Hogan Lovells
Keizersgracht 555
1017 DR Amsterdam
Netherlands

Tel: +31 20 55 33 763
Fax: +31 20 55 33 777

Email: bert.oosting@hoganlovells.com
Web: www.hoganlovells.com

Bert Oosting graduated from the University of Utrecht with a degree in Neuropsychology in 1986 and worked as a Researcher and Lecturer at the Cognitive Science and Neuropsychology Department of the University of Utrecht from 1986 through 1989. He graduated from the Law School of the University of Utrecht in 1989, was admitted to the Amsterdam Bar in 1989 when he joined Stibbe. He joined Ekelmans Den Hollander in 1996 where he became a Partner in 1998 and Co-Managing Partner in 1999 and was responsible for the merger with Lovells in 2001.

Bert is a member of the Intellectual Property Steering Committee and the Life Sciences Core Team within Hogan Lovells.

Bert’s practice encompasses all areas of Intellectual Property, Patents and Life Sciences. He regularly lectures on these areas of law and is a prolific writer and speaker on this topic.

Bert has vast experience in patent litigation in all relevant technical areas, but with a specialisation in pharmaceuticals, biotechnology and the medical devices industry. Bert not only handles patent cases before the courts in the Netherlands, but has also been involved in oppositions before the European Patent Office. Bert also advises on patent strategy, patent prosecution and enforcement strategies, as well as transactional matters such as technology transfers and licensing.

Life Sciences Law Practice:

Businesses in the life sciences industry face a multitude of complex legal challenges along the entire life of their products and concerning the organization itself.

With a network of more than 350 life sciences lawyers and specialists operating in 17 jurisdictions across the United States, Europe, Asia and the Middle East, we are global leaders in the life sciences legal field – Chambers Global 2014 ranks Hogan Lovells’ life sciences practice in band 1.

Across the full product life cycle, from initial clinical trials to off-patent strategy, from business development to defending complex litigation, we provide our clients in the pharmaceutical, biosciences and medical devices industries with an in-depth understanding of the issues affecting their business and the legal solutions they require to compete in a competitive global marketplace.

Our cross-disciplinary approach, the deep bench of talent we have in virtually every discipline, and our knowledge of and contacts with U.S., European, and Asian government agencies enable us to help clients operate or expand globally and achieve their long-term business objectives. Our team can help you navigate the legal and regulatory landscape in the countries in which you do business and advise you on import and export issues and on cross-border transactions. Wherever and whenever you need advice, we are able to support you with dedicated and experienced life sciences lawyers as well as our in-house science unit.

Hogan Lovells:

Hogan Lovells is a global legal practice that helps corporations, financial institutions, and governmental entities across the spectrum of their critical business and legal issues globally and locally. We have over 2,500 lawyers operating out of more than 40 offices in Africa, Asia, Europe, Latin America, the Middle East, and the United States.

Our practice breadth, geographical reach, and industry knowledge provide us with insights into the issues that affect our clients most deeply and enable us to provide high quality business-oriented legal advice to assist them in achieving their commercial goals.

Hogan Lovells is distinguished by a highly collaborative culture which values the contribution of our diverse team both within Hogan Lovells and in the wider community. Our style is open, service focused, and friendly. We believe that our commitment to client service, commerciality, and teamwork provides benefits to our clients and enhances effective business relationships.


Comments are closed.